Urinary Leukotriene E4 as a Biomarker of Disease Burden in Aspirin‐Exacerbated Respiratory Disease: A Retrospective Cohort Study
- 6 April 2026
- journal article
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 16 (5) , 508-511
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Long‐term clinical outcomes of aspirin‐exacerbated respiratory disease: Real‐world data from an adult asthma cohortClinical & Experimental Allergy, 2023
- Urine Leukotriene E4: Implications as a Biomarker in Chronic RhinosinusitisOtolaryngology–Head and Neck Surgery, 2021
- Elevated Urine LeukotrieneE4Is Associated With Worse Objective Markers in Nasal Polyposis PatientsThe Laryngoscope, 2020
- Aspirin-Exacerbated Respiratory DiseaseNew England Journal of Medicine, 2018